The impact of preanalytical variables on the analysis of cell-free DNA from blood and urine samples

被引:4
|
作者
Peng, Hongwei [1 ]
Pan, Ming [2 ]
Zhou, Zongning [1 ]
Chen, Congbo [3 ]
Xing, Xing [4 ]
Cheng, Shaoping [4 ]
Zhang, Shanshan [1 ]
Zheng, Hang [5 ]
Qian, Kaiyu [1 ,5 ]
机构
[1] Wuhan Univ, Zhongnan Hosp, Hubei Key Lab Urol Dis,Dept Biol Repositories, Wuhan, Peoples R China
[2] Hubei Univ Med, Taihe Hosp, Taihe Skills Training Ctr, Shiyan, Hubei, Peoples R China
[3] Hubei Univ Med, Taihe Hosp, Dept Urol, Shiyan, Hubei, Peoples R China
[4] Yangtze Univ, Affiliated Hosp 1, Dept Urol, Jingzhou, Hubei, Peoples R China
[5] Wuhan Univ, Zhongnan Hosp, Dept Urol, Lab Precis Med, Wuhan, Peoples R China
来源
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY | 2024年 / 12卷
关键词
cell-free DNA (cfDNA); preanalytical variables; standardization; blood; urine; CIRCULATING TUMOR DNA; FREE PLASMA DNA; LIQUID BIOPSY; COLLECTION TUBES; COMMERCIAL KITS; NUCLEIC-ACIDS; CANCER DIAGNOSTICS; LUNG-CANCER; DIGITAL PCR; SERUM;
D O I
10.3389/fcell.2024.1385041
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cell-free DNA (cfDNA), a burgeoning class of molecular biomarkers, has been extensively studied across a variety of biomedical fields. As a key component of liquid biopsy, cfDNA testing is gaining prominence in disease detection and management due to the convenience of sample collection and the abundant wealth of genetic information it provides. However, the broader clinical application of cfDNA is currently impeded by a lack of standardization in the preanalytical procedures for cfDNA analysis. A number of fundamental challenges, including the selection of appropriate preanalytical procedures, prevention of short cfDNA fragment loss, and the validation of various cfDNA measurement methods, remain unaddressed. These existing hurdles lead to difficulties in comparing results and ensuring repeatability, thereby undermining the reliability of cfDNA analysis in clinical settings. This review discusses the crucial preanalytical factors that influence cfDNA analysis outcomes, including sample collection, transportation, temporary storage, processing, extraction, quality control, and long-term storage. The review provides clarification on achievable consensus and offers an analysis of the current issues with the goal of standardizing preanalytical procedures for cfDNA analysis.
引用
收藏
页数:20
相关论文
共 50 条
  • [31] Whole genome deep sequencing analysis of cell-free DNA in samples with low tumour content
    Ganesamoorthy, Devika
    Robertson, Alan James
    Chen, Wenhan
    Hall, Michael B.
    Cao, Minh Duc
    Ferguson, Kaltin
    Lakhani, Sunil R.
    Nones, Katia
    Simpson, Peter T.
    Coin, Lachlan J. M.
    BMC CANCER, 2022, 22 (01)
  • [32] EDTA-mediated inhibition of DNases protects circulating cell-free DNA from ex vivo degradation in blood samples
    Barra, Gustavo Barcelos
    Santa Rita, Ticiane Henriques
    Vasques, Julia de Almeida
    Chianca, Camilla Figueiredo
    Abdalla Nery, Lidia Freire
    Soares Costa, Sandra Santana
    CLINICAL BIOCHEMISTRY, 2015, 48 (15) : 976 - 981
  • [33] Fragmentation patterns of cell-free DNA and somatic mutations in the urine of metastatic breast cancer patients
    Lin, Shaoyan
    Wang, Shusen
    Xu, Binghe
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2024, 20 (02) : 563 - 569
  • [34] Guidelines for pre-analytical conditions for assessing the methylation of circulating cell-free DNA
    Kerachian, Mohammad Amin
    Azghandi, Marjan
    Mozaffari-Jovin, Sina
    Thierry, Alain R.
    CLINICAL EPIGENETICS, 2021, 13 (01)
  • [35] Limitations and opportunities of technologies for the analysis of cell-free DNA in cancer diagnostics
    Song, Ping
    Wu, Lucia Ruojia
    Yan, Yan Helen
    Zhang, Jinny X.
    Chu, Tianqing
    Kwong, Lawrence N.
    Patel, Abhijit A.
    Zhang, David Yu
    NATURE BIOMEDICAL ENGINEERING, 2022, 6 (03) : 232 - 245
  • [36] Quantitative analysis of cell-free DNA in the plasma of gastric cancer patients
    Park, Jong-Lyul
    Kim, Hyun Ja
    Choi, Bo Youl
    Lee, Han-Chul
    Jang, Hay-Ran
    Song, Kyu Sang
    Noh, Seung-Moo
    Kim, Seon-Young
    Han, Dong Soo
    Kim, Yong Sung
    ONCOLOGY LETTERS, 2012, 3 (04) : 921 - 926
  • [37] Monitoring Plasma Cell Dyscrasias With Cell-free DNA Analysis
    Ntanasis-Stathopoulos, Ioannis
    Gavriatopoulou, Maria
    Terpos, Evangelos
    Fotiou, Despoina
    Kastritis, Efstathios
    Dimopoulos, Meletios A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (11) : E905 - E909
  • [38] Life and death of circulating cell-free DNA
    Kustanovich, Anatoli
    Schwartz, Ruth
    Peretz, Tamar
    Grinshpun, Albert
    CANCER BIOLOGY & THERAPY, 2019, 20 (08) : 1057 - 1067
  • [39] The value of cell-free DNA for molecular pathology
    Stewart, Caitlin M.
    Kothari, Prachi D.
    Mouliere, Florent
    Mair, Richard
    Somnay, Saira
    Benayed, Ryma
    Zehir, Ahmet
    Weigelt, Britta
    Dawson, Sarah-Jane
    Arcila, Maria E.
    Berger, Michael F.
    Tsui, Dana W. Y.
    JOURNAL OF PATHOLOGY, 2018, 244 (05) : 616 - 627
  • [40] Cell-free DNA in the urine of rats exposed to ionizing radiation
    Abdullaev, Serazhutdin A.
    Minkabirova, Gulchachak M.
    Bezlepkin, Vladimir G.
    Gaziev, Azhub I.
    RADIATION AND ENVIRONMENTAL BIOPHYSICS, 2015, 54 (03) : 297 - 304